Mylan launching generic version of EpiPen
Mylan says it will make available a generic version of its EpiPen, as criticism continued to mount over the price of its injectable medicine.
Court: Can drug companies pay to delay generics?
Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines that can top 90 percent.